Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2023-03-21
2023-09-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining Self-tracking Behaviors in a Mobile Intervention for Binge Eating and Weight Management
NCT04711577
Peer-Led Dissonance Eating Disorder Prevention: Virtual Delivery
NCT04433247
Conquering Feared Foods Study
NCT04155788
Focused Acceptance and Commitment Therapy (FACT)
NCT06630000
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
NCT03047005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
16-week Food Addiction Clinical Treatment (FACT) Program
16-week Food Addiction Clinical Treatment (FACT) Program, first session will be 120 mins, all subsequent sessions will be 90 mins. Treatment will be led, at a minimum, by a full licensed psychologist
16-week Food Addiction Clinical Treatment (FACT) Program
16-week Food Addiction Clinical Treatment (FACT) Program, first session will be 120 mins, all subsequent sessions will be 90 mins. Treatment will be led, at a minimum, by a full licensed psychologist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
16-week Food Addiction Clinical Treatment (FACT) Program
16-week Food Addiction Clinical Treatment (FACT) Program, first session will be 120 mins, all subsequent sessions will be 90 mins. Treatment will be led, at a minimum, by a full licensed psychologist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \>25
* YFAS \> 6/11 (severe range)
* willing to commit to a 16 week group therapy program from 4 - 5:30 pm on Thursdays in Winston-Salem, NC
* English speaking
Exclusion Criteria
* obesity medications with exception of diabetes medication with weight loss benefit (ie metformin),
* current nicotine use or substance use disorder (based on meeting the clinical cutoff for the Alcohol Use Disorders Identification Test and/or Cannabis Use Disorder Identification Test
* history of weight loss surgery,
* current/history of severe mental illness (\> 3 psychiatric hospitalizations since age 18,
* schizoaffective disorder, bipolar disorder, psychotic disorder, or personality disorder),
* current/history of lithium, abilify, saphris, vraylor, clozaril, latuda, zyprexa, seroquel, risperdal, or Geodon,
* current pregnancy or breastfeeding,
* prior diagnosis of anorexia nervosa, diagnosis of bulimia nervosa in the last 5 years,
* high currents rates of restrictive eating disorder symptoms based on the Eating Disorder Diagnosis Scale (EDDS; (i.e., any endorsement of vomiting or laxative/diuretic use to manage weight and endorsement of fasting or excessive exercise more than 2 or 3 times a week)
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shenelle Edwards-Hampton, PhD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest Health Sciences
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00053663
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.